SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 198 filers reported holding SEATTLE GENETICS INC in Q1 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,389,000 | +104.6% | 16,266 | +35.6% | 0.07% | +111.4% |
| Q4 2018 | $679,000 | -72.9% | 12,000 | -68.2% | 0.04% | -32.7% |
| Q2 2018 | $2,502,000 | +80.6% | 37,700 | +45.6% | 0.05% | +160.0% |
| Q4 2017 | $1,385,000 | -70.3% | 25,900 | -70.7% | 0.02% | -83.1% |
| Q4 2016 | $4,670,000 | +1097.4% | 88,500 | +917.2% | 0.12% | +391.7% |
| Q4 2015 | $390,000 | -65.9% | 8,700 | -70.7% | 0.02% | -72.1% |
| Q3 2015 | $1,145,000 | +175.2% | 29,700 | +245.3% | 0.09% | +36.5% |
| Q2 2015 | $416,000 | -53.2% | 8,600 | -55.9% | 0.06% | +50.0% |
| Q1 2014 | $888,000 | +62.3% | 19,500 | +56.0% | 0.04% | -14.3% |
| Q3 2013 | $547,000 | +47.4% | 12,500 | +5.9% | 0.05% | -24.6% |
| Q2 2013 | $371,000 | – | 11,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
| Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
| Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
| Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
| DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
| Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
| EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
| Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
| CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |